Irazu Oncology
PrivateLast Round
Seed
Jul 7, 2026
Total Funding Raised
$3.15M
Company Overview
Irazu Oncology operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Seed round in July 2026.
Irazu Oncology is a biotechnology company that develops next-generation cancer immunotherapies using a proprietary Outer Membrane Vesicles (OMV) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Irazu Oncology Comparables
Compare Irazu Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Baccine Ltd. | 82% | |
| EV Therapeutics | 81% | |
| BiOMViS Srl | 80% |
For institutional investors. Book with your work email.
Irazu Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 7, 2026 | ||||
| VC Round | Mar 4, 2025 | ||||
| Series A | Mar 4, 2025 | ||||
| Seed | Dec 19, 2023 | ||||
| Grant | Aug 28, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Irazu Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abell Foundation | Seed |
| TEDCO | Seed, VC Round, Grant |
| Wexford Science & Technology | Seed |
| University System of Maryland Momentum Fund | Seed |
| University of Maryland, Baltimore | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 50% MoM to 1.3K.
- Mar 4, 2025
$500K round led by TEDCO.
For institutional investors. Book with your work email.
Irazu Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Irazu Oncology's valuation, stock price, and market status.
Is Irazu Oncology a public or private company?
Irazu Oncology is a private company.
What is the current stock price of Irazu Oncology?
Irazu Oncology is a private company, so its shares have no public market price. Caplight tracks Irazu Oncology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Irazu Oncology worth (valuation)?
Valuation information for Irazu Oncology is not publicly available.
Can I buy Irazu Oncology stock?
Irazu Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Irazu Oncology's last funding round?
Irazu Oncology's most recent funding round was Seed on July 7, 2026.
Who are the main investors in Irazu Oncology?
Key investors in Irazu Oncology include Wexford Science & Technology.
Will Irazu Oncology IPO soon?
No public IPO plans have been announced for Irazu Oncology.
How can I track Irazu Oncology secondary market activity?
Caplight tracks bids, offers, and trades in Irazu Oncology's shares on secondary markets.